Funder
Japan Society for the Promotion of Science
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. De Sanctis V, Bossi P, Sanguineti G, Trippa F, Ferrari D, Bacigalupo A, Ripamonti CI, Buglione M, Pergolizzi S, Langendjik JA, Murphy B, Raber-Durlacher J, Russi EG, Lalla RV (2016) Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements. Crit Rev Oncol Hematol 100:147–166. https://doi.org/10.1016/j.critrevonc.2016.01.010
2. Villa A, Sonis ST (2016) Pharmacotherapy for the management of cancer regimen-related oral mucositis. Expert Opin Pharm 17:1801–1807. https://doi.org/10.1080/14656566.2016.1217993
3. Shankar A, Roy S, Bhandari M, Rath GK, Biswas AS, Kanodia R, Adhikari N, Sachan R (2017) Current trends in management of oral mucositis in cancer treatment. Asian Pac J Cancer Prev 18:2019–2026
4. Curra M, Soares Junior LAV, Martins MD, Santos PSDS (2018) Chemotherapy protocols and incidence of oral mucositis An integrative review. Einstein (Sao Paulo). https://doi.org/10.1590/s1679-45082018rw4007
5. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531–1539. https://doi.org/10.1002/cncr.11671